反応 #61098
ord-aaed209479704dfface6349d9138a5dc
反応方程式
反応物
試薬
反応条件
後処理
- 1その他partitioned between ethyl acetate and water
- 2その他The organic layer was separated
- 3乾燥dried over sodium sulfate
- 4ろ過filtered
- 5濃縮concentrated in vacuo
- 6その他The residue was purified by chromatography over silica gel
- 7洗浄eluted first with ethyl acetate
- 8洗浄gradient eluted with dichloromethane containing from 0 to 10% methanol
- 9その他Precipitation of the isolated product from dichloromethane with an excess of hexanes
実験手順
Crude (2S,3S)-2-{(R)-2-amino-2-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-acetylamino}-3-phenyl-N-(4-propionyl-thiazol-2-yl)-butyramide (≈0.16 mmol) was dissolved in tetrahydrofuran (10 mL) that contained diisopropylethylamine (142 μL, 105 mg, 0.81 mmol) and was transferred via cannula to a solution of diphosgene (14 μL, 23 mg, 0.12 mmol) in tetrahydrofuran (15 mL) at 0° C. The reaction mixture was stirred for 20 minutes and then partitioned between ethyl acetate and water. The organic layer was separated and dried over sodium sulfate, filtered and concentrated in vacuo. The residue was purified by chromatography over silica gel eluted first with ethyl acetate and then gradient eluted with dichloromethane containing from 0 to 10% methanol. Precipitation of the isolated product from dichloromethane with an excess of hexanes gave (2S,3S)-2-{2,5-dioxo-4-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-imidazolidin-1-yl}-3-phenyl-N-(4-propionyl-thiazol-2-yl)-butyramide as a white solid (26 mg, 27%).